Jesse McKenney

18PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersCancer cell biologyHaematologyHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 17, 2026
Long-term oncologic outcomes of patients with grade group 1 prostate cancer and pT3a disease on final pathology.

|Aug 05, 2025
Classification of prostatic adenocarcinoma as favourable/unfavourable histology has high interobserver agreement in prostate needle core biopsies.

Chien-Kuang C Ding, Huijun Xiao, Jane K Nguyen

|Jun 03, 2024
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage.

Jane K Nguyen, Lara R Harik, Eric A Klein

|Oct 06, 2023
Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase.

Chitra Rawat, Salma Ben-Salem, Nidhi Singh

|Aug 09, 2023
Anastomosing haemangioma of the adrenal gland: A clinicopathological series of seven cases.

Reza Alaghehbandan, Erick M Remer, Eren Berber

|Oct 08, 2022
Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity.

Sean R Williamson, Ondrej Hes, Kiril Trpkov

Pageof 3

Frequent Collaborators

3 joint publications

Reza Alaghehbandan

2 joint publications

Ondrej Hes

2 joint publications

Salim K Younis

2 joint publications

Kiril Trpkov